1-Deamino-8-D-arginine vasopressin as a therapy for the bleeding diathesis of renal failure

Am J Nephrol. 1984;4(1):49-51. doi: 10.1159/000166773.


The treatment of the bleeding diathesis of renal failure remains unsatisfactory. 1-Deamino-8-D-arginine vasopressin (DDAVP) has recently been shown to shorten the prolonged bleeding time of renal failure and may as a result diminish the risk of clinical hemorrhage. We describe 2 cases where DDAVP was used successfully in the management of hemorrhage in the setting of renal insufficiency.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / complications*
  • Aged
  • Arginine Vasopressin / therapeutic use*
  • Bleeding Time
  • Deamino Arginine Vasopressin / therapeutic use*
  • Female
  • Hemorrhagic Disorders / blood
  • Hemorrhagic Disorders / drug therapy*
  • Hemorrhagic Disorders / etiology
  • Humans
  • Kidney Failure, Chronic / complications*
  • Male


  • Arginine Vasopressin
  • Deamino Arginine Vasopressin